# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001613
Filing Date
2025-08-07
Accepted
2025-08-07 16:58:47
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | qnrx-20250630x10q.htm iXBRL | 10-Q | 974599
2 | EX-31.1 | qnrx-20250630xex31d1.htm | EX-31.1 | 11901
3 | EX-31.2 | qnrx-20250630xex31d2.htm | EX-31.2 | 11883
4 | EX-32.1 | qnrx-20250630xex32d1.htm | EX-32.1 | 5719
5 | EX-32.2 | qnrx-20250630xex32d2.htm | EX-32.2 | 6484
| Complete submission text file | 0001410578-25-001613.txt |  | 4855554

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | qnrx-20250630.xsd | EX-101.SCH | 45556
7 | EX-101.CAL | qnrx-20250630_cal.xml | EX-101.CAL | 31645
8 | EX-101.DEF | qnrx-20250630_def.xml | EX-101.DEF | 170094
9 | EX-101.LAB | qnrx-20250630_lab.xml | EX-101.LAB | 356700
10 | EX-101.PRE | qnrx-20250630_pre.xml | EX-101.PRE | 273660
76 | EXTRACTED XBRL INSTANCE DOCUMENT | qnrx-20250630x10q_htm.xml | XML | 677513

Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 251195123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)